N/A
Loading page data
Please wait a moment
Search Report
Loading page data
Please wait a moment
H2- receptor antagonists are a class of drugs that are generally used to treat and prevent duodenal ulcers. H2- receptor antagonists are also known as H2-blockers. H2- receptor antagonists are also used to treat gastric ulcers and for conditions, like Zollinger-Ellison disease, in which too much acid is produced by the stomach. H2- receptor antagonists are available both over-the-counter (OTC) and with the doctor's prescription.
H2- receptor antagonists are used to relieve symptoms of acid reflux, or gastroesophageal reflux disease (GERD). Some of the side effects that might occur with the H2- receptor antagonists are diarrhea, dry mouth, dry skin, headaches, constipation, trouble urinating, and others.
In rare cases, H2- receptor antagonists can cause serious side effects like agitation, hallucinations, suicidal thoughts, wheezing, changes in vision, and others. Despite their potential side effects, H2- receptor antagonists are usually a very effective treatment for conditions that cause excess stomach acid.
The increasing prevalence of peptic ulcers along with the growing number of generic manufacturers of H2-Receptor Antagonists applications are the prime factors responsible for driving the growth of the global H2-Receptor Antagonists market. Another factor like the rising prevalence of stress-induced ulcers due to changing lifestyle and diet is anticipated to fuel the growth of the global H2-Receptor Antagonists market.
However, side effects associated with H2-Receptor Antagonists are majorly responsible for hampering the growth of the global H2-Receptor Antagonists market. Moreover, changing government policies and limited R&D activities might hamper the market growth of H2-Receptor Antagonists.
The global market for H2-Receptor Antagonists is segmented on basis of types of H2-Receptor Antagonists drug class, dosage form, application, distribution channel, and geography.
North America and Europe H2-Receptor Antagonists market are collectively expected to hold maximum market share in the global H2-Receptor Antagonists market. This is majorly due to the presence of established key players and high-quality healthcare infrastructure, in the regions. Emerging countries of Asia Pacific H2-Receptor Antagonists market is expected to witness rapid growth due to the lucrative market opportunities in the global H2-Receptor Antagonists market.
However, due to lack of awareness healthcare facilities in the low middle-income courtiers of Latin America and the Middle East and Africa region, there is the significant reduction in the demand of H2-Receptor Antagonists, which is expected to deter the growth of H2-Receptor Antagonists market globally.
The key players present in the global H2-Receptor Antagonists Market are Perrigo Company plc (Paddock Laboratories, Inc), Hospira, Inc., Mylan N.V., Fresenius SE & Co. KgaA, Teva Pharmaceutical, Apotex Inc., GlaxoSmithKline plc, and others.
